Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | ALB | P02768 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.52 |
| ▸ | CXCR2 | P25025 | 2/20 | 0.49 |
| ▸ | HNF4A | P41235 | 1/20 | 0.48 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11113016 | 0.82 | CXCR2 (0.44) | ALDH1A1KDM4ECXCR2SMN1; SMN2NOTUM | |
| SCHEMBL7178852 | 0.82 | ALDH1A1 (0.53) | ALDH1A1KDM4EHPGDALBHSD17B10 | |
| SCHEMBL180853 | 0.81 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDHMGB1ALOX15 | |
| SCHEMBL29365220 | 0.81 | ALDH1A1 (0.56) | ALDH1A1KDM4EHPGDHMGB1ALOX15 | |
| SCHEMBL4851536 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4EHPGDALBHSD17B10 | |
| SCHEMBL27869030 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KDM4EHPGDALBHSD17B10 | |
| SCHEMBL6908405 | 0.79 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDHMGB1ALOX15 | |
| SCHEMBL6914996 | 0.79 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDHSD17B10HMGB1 | |
| SCHEMBL6913178 | 0.79 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDHMGB1ALOX15 | |
| SCHEMBL6913805 | 0.79 | ALDH1A1 (0.54) | ALDH1A1KDM4EHPGDHMGB1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250230168-A1 | AZASPIRO WRN INHIBITORS | GILEAD SCIENCES, INC. | 2025-07-17 | — | — | US | disclosed |
| WO-2025137640-A1 | AZASPIRO WRN INHIBITORS | GILEAD SCIENCES, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-105886565-A | Method for producing cyano hydroxyl benzoic acid from microorganisms | 青岛科技大学 | 2016-08-24 | — | — | CN | disclosed |
| CN-105886565-A | Method for producing cyano hydroxyl benzoic acid from microorganisms | 青岛科技大学 | 2016-08-24 | — | — | CN | disclosed |
| EP-1871844-B1 | BUBBLE COMPOSITION WITH COLOR CHANGING INDICATOR | C2C TECHNOLOGIES LLC (US) | 2014-08-27 | — | — | EP | disclosed |
| US-8703750-B2 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2014-04-22 | — | — | US | disclosed |
| EP-1958940-B1 | CONDENSATION REACTION BY METAL CATALYST | TAKASAGO PERFUMERY CO LTD (JP) | 2013-06-26 | — | — | EP | disclosed |
| US-20110098479-A1 | CONDENSATION REACTION BY METAL CATALYST | MASHIMA KAZUSHI | 2011-04-28 | — | — | US | disclosed |
| US-7888513-B2 | Condensation reaction by metal catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100317519-A1 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2010-12-16 | — | — | US | disclosed |
| WO-2005094580-A1 | MIXTURES AND METHODS FOR THE INDUCTION OF RESISTANCE IN PLANTS | ISAGRO S.P.A. (IT) | 2005-10-13 | — | — | WO | disclosed |
| US-20050192318-A1 | Compounds | ASTRAZENECA AB (SE) | 2005-09-01 | — | — | US | disclosed |
| US-6924277-B2 | Cyclized benzamide neurokinin antagonists for use in therapy | ASTRAZENECA AB (SE) | 2005-08-02 | — | — | US | disclosed |
| US-20040029850-A1 | Cyclized benzamide neurokinin antagonists for use in therapy | ASTRA ZENECA AB (SE) | 2004-02-12 | — | — | US | disclosed |
| EP-1324992-A1 | CYCLIZED BENZAMIDE NEUROKININ ANTAGONISTS FOR USE IN THERAPY | AstraZeneca AB (SE) | 2003-07-09 | — | — | EP | disclosed |
| WO-2002026724-A1 | CYCLIZED BENZAMIDE NEUROKININ ANTAGONISTS FOR USE IN THERAPY | ASTRAZENECA AB (SE) | 2002-04-04 | — | — | WO | disclosed |
| US-6251882-B1 | TREATING LEUKEMIA, BREAST CANCER, PROSTATE CANCER, OR BRAIN TUMOR | PARKER HUGHES INSTITUTE | 2001-06-26 | — | — | US | disclosed |
| EP-1091934-A2 | ALKYL KETONES AS POTENT ANTI-CANCER AGENTS | Parker Hughes Institute (US) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000000469-A2 | ALKYL KETONES AS POTENT ANTI-CANCER AGENTS | PARKER HUGHES INSTITUTE (US) | 2000-01-06 | — | — | WO | disclosed |
| US-4146631-A | ANTIALLERGENS, RESPIRATORY DISORDERS | MAY & BAKER LIMITED (GB) | 1979-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250230168-A1 | AZASPIRO WRN INHIBITORS | WRN, RECQL, BLM | ALDH1A1 1316/4885KDM4E 3650/4885HPGD 583/4885 |
| US-20110098479-A1 | CONDENSATION REACTION BY METAL CATALYST | C9, CBR3, C1R | ALDH1A1 2265/4885KDM4E 1848/4885HPGD 4312/4885 |
| US-20100317519-A1 | Mixtures and methods for the induction of resistance in plants | SLC11A2, MYD88, ME2 | ALDH1A1 2944/4885KDM4E 4408/4885HPGD 90/4885 |
| US-20050192318-A1 | Compounds | PCSK9, CYP11B2, CYP27A1 | ALDH1A1 1381/4885KDM4E 4125/4885HPGD 419/4885 |
| US-20040029850-A1 | Cyclized benzamide neurokinin antagonists for use in therapy | BDKRB1, BDKRB2, NPY1R | ALDH1A1 2186/4885KDM4E 3742/4885HPGD 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.